CHM
Click for more information
6.90% 2.7¢ chimeric therapeutics limited

Ann: 1st patient dosed in Phase 1b recurrent glioblastoma trial, page-17

  1. cklamov
    260 Posts.
    lightbulb Created with Sketch. 49
    clock Created with Sketch.
    02/11/23
    15:42
    Post #: 70693188
    part B of the trial, a dose expansion
    phase will enroll 12-26 patients
    CHM Price at posting: 3.0¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 3  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply
 

Featured News

MTL Mantle Minerals to kick off drilling at Mt Berghaus in WA
right-arrow Created with Sketch.
AL3 AML3D to investigate copper-nickel alloy printing for US Defence
right-arrow Created with Sketch.
NEWS Download the latest Thematics Insights Report: What it takes to get a new drug to market in Australia
right-arrow Created with Sketch.
AWJ Auric sends off first gold to Perth Mint of 2024
right-arrow Created with Sketch.
ADX 4DMedical partners with West Los Angeles VA Medical Center for Veteran lung imaging study
right-arrow Created with Sketch.
AUQ Alara Resources is driving Oman into a renewable renaissance with accelerating copper production
right-arrow Created with Sketch.

Top Stories

watchlist Created with Sketch. Add CHM (ASX) to my watchlist
(20min delay)
Last
2.7¢ 		Change
-0.002(6.90%) 		Mkt cap ! $23.12M
Open High Low Value Volume
2.9¢ 2.9¢ 2.7¢ $27.62K 1.008M

Buyers (Bids)

No. Vol. Price($)
8 1285000 2.7¢
 

Sellers (Offers)

Price($) Vol. No.
2.8¢ 964632 2
View Market Depth
Last trade - 15.59pm 08/05/2024 (20 minute delay) ?
Last
2.7¢ 		  Change
-0.002 ( 3.57 %)
Open High Low Volume
2.8¢ 2.8¢ 2.7¢ 307256
Last updated 14.05pm 08/05/2024 ?
CHM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.